關於 zafirlukast ，我們在網路上蒐集到這些相關的討論、資訊與評價

#11. Accolate (zafirlukast) dosing, indications, interations, adverse ...

USES: Zafirlukast is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you ...

#12. Zafirlukast: Uses, Interactions, Mechanism of Action - DrugBank

Zafirlukast is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma, often used in conjunction with an inhaled steroid ...

#13. Zafirlukast Oral: Uses, Side Effects, Dosages - Verywell Health

Zafirlukast is an oral prescription tablet used for the long-term management of asthma. Accolate, the brand version of zafirlukast, ...

#14. Zafirlukast - an overview | ScienceDirect Topics

Zafirlukast is a leukotriene LTD4 and LTE4 receptor antagonist Back (2002). Inhibition of LTD4 and LTE4 reduces the bronchoconstriction and increased pulmonary ...

#15. ACCOLATE - zafirlukast tablet, film coated - Accessdata.fda.gov

Zafirlukast is a synthetic, selective peptide leukotriene receptor antagonist (LTRA), with the chemical name 4-(5-cyclopentyloxy.

#16. Zafirlukast (Accolate): Basics, Side Effects & Reviews - GoodRx

Zafirlukast (Accolate) is a leukotriene receptor antagonist. It helps by stopping inflammatory cells, called leukotrienes, from constricting (closing) your ...

#17. Zafirlukast tablets - Cleveland Clinic

ZAFIRLUKAST (za FIR loo kast) is used to prevent and treat the symptoms of asthma. Do not use for an acute asthma attack.

#18. Summary of Clinical Trials with Zafirlukast - ATS Journals

Zafirlukast is a potent and selective cysteinyl leukotriene (cysLT) antagonist that has been approved for the prophylactic treatment of asthma.

#19. zafirlukast (Accolate) for Asthma Side Effects, Dosing, and Uses

Zafirlukast is an oral leukotriene receptor antagonist used for treating asthma. Leukotrienes are a group of chemicals manufactured in the body from arachidonic ...

#20. Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer

This is a single-arm Simon two-stage phase 2 clinical trial to determine whether zafirlukast reduces the tumor marker CA-125 as well the ...

#21. ZAFIRLUKAST的用法與用量、成分、適應症、副作用|藥典

ZAFIRLUKAST 的用法與用量、成分、適應症、副作用，ZAFIRLUKAST仿單與說明資料|藥典|KingNet國家網路醫藥|Second Opinion.

#22. Zafirlukast for asthma (Accolate) - Patient.info

About zafirlukast ; Type of medicine, A leukotriene receptor antagonist ; Used for, Asthma (for adults and for children aged over 12 years) ; Also ...

#23. Zafirlukast and Churg-Strauss Syndrome - JAMA Network

To the Editor.—Dr Wechsler and colleaguesdescribe patients taking zafirlukast (Accolate) for asthma who develop Churg-Strauss syndrome following ...

#24. Synthesis of Asthma Drug Zafirlukast (Accolate) Using ...

The FDA-approved drug for the treatment of asthma, zafirlukast, is synthesized engaging multiple catalytic reactions including a new method ...

#25. Zafirlukast (ICI-204219) | ≥99%(HPLC) - Selleck Chemicals

Zafirlukast (ICI-204219) is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms. Targets. leukotriene receptor. In ...

#26. zafirlukast | Ligand page - IUPHAR/BPS Guide to ...

Comment: Zafirlukast is an oral leukotriene receptor antagonist (LTRA), with selectivity for cysteinyl leukotriene receptor 1 (CysLT1 receptor).

#27. Zafirlukast Is a Dual Modulator of Human Soluble Epoxide ...

The cysteinyl leukotriene receptor 1 antagonists (CysLT1RA) montelukast, zafirlukast and pranlukast (Figure 1) were initially developed for the ...

#28. Zafirlukast | SpringerLink

Zafirlukast is a competitive and selective leukotriene receptor antagonist indicated for the prophylaxis and treatment of chronic asthma.

#29. KEGG DRUG: Zafirlukast

Zafirlukast D00411 Zafirlukast (JAN/USAN/INN) Drug groups [BR:br08330] Anti-allergic agent. DG01541 Cysteinyl leukotriene receptor antagonist

#30. Montelukast and zafirlukast in asthma - Drug and ...

▽Montelukast (Singulair - Merck Sharp & Dohme) and ▽zafirlukast (Accolate - Zeneca) are two of a new class of drugs for the treatment of asthma that have ...

#31. Zafirlukast | CAS 107753-78-6 | SCBT

Zafirlukast, CAS: 107753-78-6, is A potent and selective CysLT1 receptor antagonist. MF: C31H33N3O6S, MW: 575.68. Cited in 2 publications.

#32. Zafirlukast - Australian Prescriber - NPS MedicineWise

Although zafirlukast has been approved for the treatment and prophylaxis of asthma in patients over 12 years of age, its main role will be in prevention.

#33. Zafirlukast: Indication, Dosage, Side Effect, Precaution - MIMS

Zafirlukast : Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, .

#34. Zafirlukast inhibits the growth of lung adenocarcinoma via ...

We identified a drug candidate, Zafirlukast (ZAF), clinically approved for the treatment of asthma, that could inhibit the TMEM16A channel ...

#35. Zafirlukast (CAS Number: 107753-78-6) | Cayman Chemical

Zafirlukast is a cysteinyl leukotriene 1 (CysLT1) receptor antagonist (IC50 = 0.014 μM in a cell-based calcium mobilization assay).

#36. Zafirlukast (Accolate): A New Treatment for Capsular ...

Patients received a regimen of zafirlukast 20 mg by mouth 2 times daily for 3 months. Results. In many cases, dramatic softening of the breast capsule was ...

#37. Leukotriene receptor antagonists | Asthma | CKS

Montelukast and zafirlukast are leukotriene receptor antagonists taken orally in the treatment of asthma. Doses are as follows:.

#38. Zafirlukast | Sigma-Aldrich

zafirlukast. " 范围网站内容. 产品基因论文技术文档网站内容. Filter & Sort. Leukotriene Receptors. We offer many products related to leukotriene ...

#39. Zafirlukast Definition & Meaning | Merriam-Webster Medical

The meaning of ZAFIRLUKAST is a leukotriene antagonist C31H33N3O6S that is administered orally to inhibit bronchoconstriction in the treatment of asthma.

#40. Zafirlukast: View Uses, Side Effects and Medicines | 1mg

You have been prescribed Zafirlukast for asthma prevention and for the treatment of allergy symptoms such as sneezing and runny nose.

#41. Zafirlukast: The First Leukotreene-Receptor Antagonist ...

ObjectiveTo review the pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of zafirlukast. Therapeutic issues regarding the use of a ...

#42. Zafirlukast - Indications, Dosage, Side Effects and Precautions

Zafirlukast (Accolate) generic is an oral leukotriene receptor antagonist (LTRA), prescribed for asthma. It blocks the action of certain natural substances ...

#43. zafirlukast - Wiktionary

zafirlukast (uncountable). (pharmacology) A leukotriene antagonist C31H33N3O6S that is administered orally to inhibit bronchoconstriction in the treatment ...

#44. Zafirlukast Oral Tablet Drug Information, Side Effects, Faqs

ZAFIRLUKAST (za FIR loo kast) is used to prevent and treat the symptoms of asthma. Do not use for an acute asthma attack.

#45. Zafirlukast | Davis's Drug Guide for Rehabilitation Professionals

"Zafirlukast." Davis's Drug Guide for Rehabilitation Professionals Ciccone CD. Ciccone C.D.(Ed.),Ed. Charles D. Ciccone. McGraw Hill, 2016, https://fadavispt ...

#46. Zafirlukast | C31H33N3O6S | ChemSpider

Structure, properties, spectra, suppliers and links for: Zafirlukast, 107753-78-6.

#47. Zafirlukast improves asthma symptoms and quality of life in ...

Background: Previous trials demonstrated the effectiveness of the leukotriene receptor antagonist zafirlukast in patients with mild-to-moderate asthma.

#48. zafirlukast - DrugCentral

zafirlukast Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |. Stem definition, Drug id, CAS RN. leukotriene receptor antagonists, 2855, 107753 ...

#49. Accolate ® (zafirlukast) Tablets - Par Pharmaceutical

NDC Generic Name Compare to Brand NDC49884‑0589‑02 Generic NameAccolate ® (Zafirlukast Tablets) Compare to BrandAccol... NDC49884‑0590‑02 Generic NameAccolate ® (Zafirlukast Tablets Compare to BrandAccol...

#50. Environmental Risk Assessment Data Zafirlukast - AstraZeneca

The octanol-water partition coefficient is low; therefore, zafirlukast is not predicted to bioaccumulate in aquatic organisms. The Predicted Environmental ...

#51. zafirlukast - PharmGKB

zafirlukast ; Accolate. The information on this website is not intended for direct diagnostic use or medical decision-making without review by a health care ...

#52. Zafirlukast | Memorial Sloan Kettering Cancer Center

Zafirlukast. Adult Medication. Share. Print. This information from Lexicomp ® explains what you need to know about this medication, including what it's used ...

#53. Does zafirlukast reduce future risk of asthma exacerbations in ...

Our study suggests that zafirlukast, as the first-line therapy, significantly reduces mild to moderate but not severe asthma exacerbations.

#54. Novel zafirlukast derivatives exhibit selective antibacterial ...

Periodontal disease is an oral chronic immune-inflammatory disease highly prevalent worldwide that is initiated by specific oral bacterial species leading ...

#55. Zafirlukast – Medicines – SPS - Specialist Pharmacy Service

Zafirlukast · dm+d · Articles · Medicine Compliance Aid Stability · Lactation Safety Information · Learn more about us or ask for help · Medicines ...

#56. zafirlukast Uses, Side Effects, Dosage & Interactions

What are the possible side effects of zafirlukast (Accolate)?. Get emergency medical help if you have signs of an allergic reaction: hives, ...

#57. Zafirlukast (ICI 204219) | Leukotriene Receptor Antagonist

Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and ...

#58. Zafirlukast for asthma prevention (prophylaxis) - Medicines For ...

Zafirlukast should not be used during an acute asthma attack (sudden onset of wheezing and breathlessness). Use your child's reliever medicine (usually a ...

#59. zafirlukast | healthdirect

More information is available on zafirlukast including side effects, age restrictions, food interactions, whether the medicine is available at a government ...

#60. Zafirlukast - Oral | HealthLink BC

Zafirlukast is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you ...

#61. Zafirlukast - Drug Information - Kaiser Permanente

Drug Information. Zafirlukast is used in the prevention and treatment of mild to severe asthma , seasonal allergic asthma, exercise-induced asthma, and ...

#62. US warns on zafirlukast - The Lancet

Six asthma patients taking the leukotriene receptor antagonist zafirlukast have developed Churg-Strauss syndrome, said the US Food and Drug ...

#63. zafirlukast – Health Information Library | PeaceHealth

Keep using zafirlukast as directed, even if you have no asthma symptoms. If you take oral steroid medicine, do not stop it suddenly. Ask your doctor about ...

#64. Zafirlukast 107753-78-6 | TCI AMERICA

Zafirlukast · Cyclopentyl N-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamate · N-[3-[[2-Methoxy-4-[[[(2 ...

#65. Zafirlukast Definition & Meaning | Dictionary.com

A leukotriene receptor antagonist that reduces inflammation and is used to treat asthma. QUIZ. GOOSES. GEESES. I WANT THIS QUIZ ON PLURAL NOUNS!

#66. ZAFIRLUKAST ( Accolate ) - 全球華人藥物資訊網

扎鲁司特片 ... 此藥為一種「leukotriene的拮抗劑」，可以用來防止和治療氣喘(哮喘)的症狀。 當我們吸入花粉或動物毛髮等過敏原後，體內會自然釋放出與敏性反應有關的物質 ...

#67. Zafirlukast - Amazon Pharmacy

Zafirlukast (Generic for Accolate, Oral Tablet). Sample image ... ZAFIRLUKAST (za FIR loo kast) is used to prevent and treat the symptoms of asthma.

#68. Showing metabocard for Zafirlukast (HMDB0014689)

Zafirlukast is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma, often used in conjunction with an inhaled ...

#69. Asthma drug zafirlukast (Accolate): serious hepatic events

Reason for posting: Zafirlukast is an oral leukotriene receptor antagonist used in the treatment of chronic asthma. Since the drug was first ...

#70. Zafirlukast - Rx Outreach

USES: Zafirlukast is used to prevent asthma symptoms and to decrease the number of asthma attacks in people 5 and older. It helps make breathing easier by ...

#71. Zafirlukast (Accolate) | Davis's Drug Guide

Find information on Zafirlukast (Accolate) in Davis's Drug Guide including dosage, side effects, interactions, nursing implications, mechanism of action, ...

#72. Zafirlukast - wikidoc

FDA-Labeled Indications and Dosage (Pediatric). Zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and ...

#73. Comparison of The Treatment Efficacy of Montelukast and ...

Leukotriene antagonists (zafirlukast, montelukast) are drugs used in the treatment of asthma for a long time. Studies have been published reporting that these ...

#74. Drug Notes - Zafirlukast (By mouth) - ADAM

Zafirlukast (By mouth). Zafirlukast (za-fir-LOO-kast). Treats asthma and prevents asthma attacks. Brand Name(s):. Accolate.

#75. ZAFIRLUKAST - Inxight Drugs

Zafirlukast is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma, often used in conjunction with an inhaled steroid ...

#76. Discovery of Zafirlukast as a novel SARS-CoV-2 helicase ...

Zafirlukast, a leukotriene receptor antagonist used to treat chronic asthma, achieved the lowest docking score at −8.75 kcals/mol.

#77. Efficacy and duration of action of the antileukotriene zafirlukast ...

The objectives of the study were to assess the magnitude of the effect of the leukotriene receptor antagonist, zafirlukast, against cold air-induced ...

#78. zafirlukast [TUSOM | Pharmwiki] - TMedWeb

Zafirlukast · Trade Name: Accolate ® · Drug Category: Leukotriene receptor antagonist · Mechanism of Action: Leukotriene receptor (LTD4 and LTE4) ...

#79. Accolate (zafirlukast) | CenterWatch

Accolate (zafirlukast) is a synthetic, selective peptide leukotriene receptor antagonist (LTRA). Accolate is specifically indicated for the prophylaxis and ...

#80. A Cysteinyl Leukotriene Receptor Antagonist for Asthma

Clinical trials show that zafirlukast improves symptoms, peak expiratory flow rate and FEV1 in chronic asthma. These effects are similar to cromolyn sodium but ...

#81. Zafirlukast - APExBIO

Zafirlukast is a leukotriene receptor antagonist (LTRA). (IC50=0.6 uM, IC50=7.0 uM for CYP2C9)

#82. zafirlukast - Associates for Women's Medicine

What is the most important information I should know about zafirlukast? Tell your doctor right away if you have signs of blood vessel inflammation: flu-like ...

#83. zafirlukast - Definition | OpenMD.com

Definitions related to zafirlukast: A drug used to prevent and treat symptoms of asthma. It blocks substances that cause inflammation in the lungs. It is a type ...

#84. zafirlukast - 英語_讀音_用法_例句 - 海词

Daily zafirlukast therapy did not differ significantly from intermittent treatment in any outcome measured. 每天扎魯司特治療與間斷治療相比任何檢測的轉歸都 ...

#85. Treatment of atopic dermatitis with zafirlukast - eScholarship

At 4 weeks of zafirlukast therapy, pruritus was markedly reduced, allowing for weaning of ultraviolet light treatments and reduction of topical corticosteroid ...

#86. Zafirlukast | Asociación Española de Pediatría

Descripción: Antagonista de los receptores de los cisteinil-leucotrienos con formulación exclusivamente oral, indicado en el tratamiento de ...

#87. zafirlukast - Annapolis, Bowie, Millersville, MD

What is the most important information I should know about zafirlukast? Tell your doctor right away if you have signs of blood vessel inflammation: flu-like ...

#88. Acute hepatocellular injury associated with zafirlukast

Zafirlukast, a competitive and selective leukotriene-receptor antagonist recently approved for the prophylaxis and chronic treatment of asthma, ...

#89. zafirlukast | Ear, Nose, Throat, Balloon Sinuplasty

What is the most important information I should know about zafirlukast? Tell your doctor right away if you have signs of blood vessel inflammation: flu-like ...

#90. zafirlukast - Lancaster General Health

What is the most important information I should know about zafirlukast? Tell your doctor right away if you have signs of blood vessel inflammation: flu-like ...

#91. Zafirlukast and Churg-Strauss Syndrome - CHEST

In their case report, within 1 month of taking zafirlukast for worsening asthma, the patient developed a biopsy-proven eosinophilic vasculitic rash, pulmonary ...

#92. Best 3 Definitions of Zafirlukast - YourDictionary

Define zafirlukast. Zafirlukast as a noun means A drug that acts as a leukotriene receptor antagonist, reduces the inflammatory process, and is used to ...

#93. Zafirlukast

Zafirlukast. Structural Formula Vector Image. Title: Zafirlukast. CAS Registry Number: 107753-78-6.

#94. Zafirlukast promotes insulin secretion by increasing calcium ...

The zafirlukast has been reported to be anti-inflammatory and widely used to alleviate the symptoms of asthma. However, its influence on ...

#95. 107753-78-6 | Zafirlukast - Toronto Research Chemicals

Chemical Name, Zafirlukast. Synonyms, [3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic Acid ...

#96. Zafirlukast - Camber Pharmaceuticals

Zafirlukast. Note: product and packaging images are not actual size. NDC#31722-007-60; UPC Code331722007603; Imprint16, V; GPI Code44505080000310.

#97. Thermo Scientific Zafirlukast

This Thermo Scientific brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the ...

#98. Zafirlukast | ≥99%(HPLC) | LTD4 receptor antagonist | AdooQ®

Zafirlukast is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Solubility *. In vitro (25° ...